Navigation Links
Orbita and ERT Collaborate to Optimize Data Capture, Insights for Pharmaceutical and Device Trials via Amazon Echo-based Voice Assistants

Orbita’s Nathan Treloar will discuss the role of voice-powered healthcare applications during a full-day workshop on Tuesday, May 23, 2017 in San Francisco. Titled Connected Health and IoT: Technology Innovators and Disruption, the workshop is part of Connections: The Premier Connected Home Event hosted by Parks Associates, a market research and consulting firm specializing in emerging consumer technology products and services.

Orbita, Inc., a leading provider of voice-first software for connected home healthcare announced today a collaboration with ERT to research innovative new approaches to data procurement and management for pharmaceutical and device customers seeking to streamline clinical trials. The collaboration combines the advanced capabilities of ERT’s EXPERT™ technology platform for clinical trial data collection, processing, and analysis with Orbita Voice™, a first-of-its-kind solution for creating conversational applications using intelligent voice agents such as Amazon Alexa and Google Assistant.

“ERT is continually collaborating with clinical trial sponsors and technology experts to ideate and test the application of innovative technologies in clinical development,” said Andrea Valente, executive vice president and chief development officer at ERT. “We’re excited to work with Orbita on this solution and to give patients the power of voice - an important, emerging technology - to complete surveys, verify completion of care pathway tasks and report health concerns, all of which enables pharmaceutical researchers to move ahead in their clinical development programs quickly, and with confidence.”

Orbita Voice is the first healthcare-centric solution designed to easily create and manage intelligent, conversational skills for voice-powered assistants such as Amazon Echo and Google Home. Clinical trial investigators and coordinators use Orbita Voice’s intuitive tools to create interactive voice surveys and collect voice responses, and use built-in analytics to track user engagement and respond to user input.

Using the combined ERT and Orbita solution, clincial trial study coordinators can create and manage care plans by setting care goals, tasks, and rules over a specified timeline, including completion of daily pain assessment surveys, wellness tasks, or vitals measurements. Patients and family members can review and manage care tasks via voice as well as in mobile phone and web environments.

Nathan Treloar, Orbita president, said, “We are thrilled to be working with ERT to bring next-generation technologies to the forefront for clinical trial sponsors and participants. ERT’s leadership in the clinical trials industry and their creativity in blending Orbita Voice with the advanced capabilities of their own EXPERT™ technology platform make them an ideal partner to deliver transformative solutions to this market.”

According to Harry Wang, senior director of research at Parks Associates, “Voice-based UI innovations have huge implications for the healthcare industry, particularly in areas where patient participation, interaction, and engagement is critical to the market success of digital health solutions and services. This collaboration between Orbita and ERT is a clear example of voice recognition technology’s potential in healthcare and we expect many more use cases that incorporate voice UI to emerge.”

At the end of 2016, 45% of U.S. smartphone owners reported using a voice-enabled personal assistant through an app or dedicated device and that figure rises to 63% of millennial smartphone owners.

About Orbita
Orbita is an innovator of connected home healthcare solutions that dramatically increase patient engagement, optimize care coordination, improve outcomes, and reduce costs. Healthcare organizations, device manufacturers and service providers use Orbita’s cloud platform and care journey management solutions to create, deploy and manage secure, connected healthcare applications that combine data from wearables and other connected devices into collaborative care experiences. Orbita’s voice-first solutions enable quick, easy development and management of intelligent voice assistants based on Amazon Alexa, Google Assistant and other voice platforms.

About ERT
ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that our customers can move ahead with confidence. With more than 45 years of clinical and therapeutic experience, ERT balances knowledge of what works with a vision for what’s next, so it can adapt without compromising standards. Powered by the company’s EXPERT® technology platform, ERT’s solutions enhance trial oversight, enable site optimization, increase patient engagement, and measure the efficacy of new clinical treatments while ensuring patient safety. Over the past four years, more than half of all FDA drug approvals came from ERT-supported studies. Pharma companies, Biotechs, and CROs have relied on ERT solutions in 9,500+ studies spanning three million patients to date. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly – and with confidence.

Contact: Beth Strohbusch, Orbita PR Director, beth(at)orbita(dot)ai, +1 (414) 213-8818

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related medicine news :

1. Orbita™ Engage Provides Complete Patient Engagement for Connected Home Healthcare
2. Healthwise and Orbita will Showcase Amazon Echo-powered Healthcare Knowledge Assistant at HIMSS 2017, Orlando, February 19-23, Booth #1523
3. IVCi and Orbita Partner to Bring Video Collaboration to Connected Home Healthcare
4. Orbita Announces Breakthrough in Voice Assistant Technologies for Home Healthcare
5. Oculoplastic Surgeon Discusses NBA Star Derrick Rose's Orbital Fracture Injury and Recovery
6. Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders
7. Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed
8. NCAA and LEAD1 Association to Collaborate on Insurance Study for Student-Athletes
9. PCAB Collaborates on Consensus Statement on Handling of Hazardous Drugs per USP Chapter
10. ASCP Collaborates in Multidisciplinary Approach to Diagnosis and Treatment of Acute Myeloid Leukemia (AML)
11. AIS Health, Magellan Rx Management Collaborate on Webinar to Share New Insights on Medical Pharmacy Spend, Trend and Management Tools
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based ... and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored ... 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in wound care advancements to physician colleagues, skilled nursing facility medical directors and ... the Treacherous Waters of Wound Care." , "At many of these conferences we ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Divoti USA will engrave and process all non-coated ... latest FDA requirements, which stipulates new criteria regarding medical device manufacture ... Medical ID jewelry such as Medical ID Bracelets, can rest assured ... of the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving process ...
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
Breaking Medicine Technology: